The present study describes the changes in expression of hydroxy-carboxylic acid receptor 2 (HCA2 receptor) in femoral epiphysis and metaphysis of rats with glucocorticoid-induced osteoporosis (GIO). 16 growing male Sprauge dawley rats were randomly divided into two equal groups consisting of normal control and rats that were rendered osteoporotic by receiving 0.1 mg/kg/day dexamethasone subcutaneously. After 4 weeks, all rats were sacrificed and immediately right and left femoral bones were removed for RT-qPCR and histological examination, respectively. Immunohistochemical parameters using a primary rabbit polyclonal GPR109A antibody in hematoxylin and eosin-counter stained slides were determined. HCA2 receptor expression was evaluated using RT-qPCR. Qualitative and histomorphometric evaluation of slides revealed the establishment of glucocorticoid-induced osteoporosis (GIO) in rats treated with dexamethasone. In immunohistochemical study, dexamethasone administration appreciably reduced receptor density in all evaluated cell types and in total slides as compared to control. mRNA level of HCA2 receptor gene was reduced in dexamethasone-treated group. GIO may be associated with down regulation of HCA2 receptors in proximal femoral bone of rats at mRNA as well as protein level in no-cell type-specific manner, although reduction in protein expression needs to be further confirmed by western blotting.
The primary action of GCs is on osteoblasts, where by decreasing replication and impairing differentiation and maturation, may lead to decreased bone formation (6, 7) . Osteocytes are also affected (8) and increased bone resorption is observed in the early phase of GC treatment (9) . It is believed that disruption of bone marrow microcirculation and increased adipogenesis contribute to GIO development, although currently no available anti-osteoporosis agent specifically targets microcirculation and bone marrow adipogenesis (10) .
In a microarray analysis study performed by Yao et al., 2008 , GC excess in mice was associated with early activation of genes associated with osteoclastogenesis and adipogenesis and a later suppression of genes associated with osteogenesis and mineralization (11) .
The hydroxy-carboxylic acid receptor 2 (HCA2 receptor) is a G-protein coupled receptor (GPCR) and serves as the target of antidyslipidemic drug nicotinic acid (or niacin) (12-14) a drug which has been in use since the 1950's (15) and is still the most efficacious drug approved to raise HDL cholesterol plasma levels (16) . These receptors are predominantly expressed on adipocytes and mediate the inhibition of lipolysis by coupling to G i -type proteins (17) . Adipocytes can "sense" metabolic changes in the environment by these cell surface receptors and respond through lipolytic regulation (18).
To better elucidate the possible relationship between lipid homeostasis and GIO, the present study describes the changes in expression of HCA2 receptors in femoral epiphysis and metaphysis of rats with GIO at both mRNA and protein levels by using quantitative real-time polymerase chain reaction (RT-qPCR) and immunohistochemical methods.
Materials and methods

Study design
Sixteen growing male Sprauge dawley rats with a mean body weight of 150 g were randomly divided into two equal groups consisting of normal control group (CG) that was left without drug treatment, and osteoporotic group that received 0.1 mg/kg/day dexamethasone sodium phosphate were randomly assayed and the mean HSB value was calculated. HSB value of the total slide (including bone marrow and trabeculae) was also determined.
RNA isolation and RT-qPCR
Samples weighing 50-100 mg, from proximal epiphysis and metaphysis of right femoral bones 
Statistical analyzes
Data were presented as mean±SD and analyzed by two independent samples MannWhitney U test except for the result of RT-qPCR that was analyzed by independent samples t-test. A significance level of p<0.05 was considered for all comparisons. 
Results
Confirmation of GIO by histomorphometric
evaluation
Qualitative evaluation of slides revealed the presence of GIO in rats treated with dexamethasone with more marrow spaces between thinned trabeculae without a change in their connectivity (Fig. 1) . In quantitative evaluation, all measured histomorphometric parameters were significantly lower in dexamethasone-treated group as compared to control (p<0.05). Data are presented in Table 1 . (Fig. 2) . Due to scarcity of osteoclasts in the histological slides, we were not able to quantify receptor density in this type of cell, although they were positive for receptor expression.
Immunohistochemical evaluation of receptor protein expression
Evaluation of HCA2 receptor mRNA expression by RT-qPCR
RNAs isolated from femoral samples were used for RT-qPCR to determine whether mRNA transcripts encoding HCA2 receptors were present in analyzed samples. It should be mentioned that due to low number of osteoclasts in histological sections we were not able to quantify receptor density in this cell type. In conclusion, GIO may be associated with down regulation of HCA2 receptors in proximal femoral bone of rats at mRNA level as well as protein expression in no cell type-specific manner, although reduction in protein expression needs to be further confirmed by western blotting.
